Alessandra Bersiga
- Cancer Research top 2%
- Breast Cancer Treatment Studies 11
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 5%
- HER2/EGFR in Cancer Research 5
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 3
-
- Estrogen and related hormone effects 5
-
- Urinary and Genital Oncology Studies 3
-
- PI3K/AKT/mTOR signaling in cancer 2
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Alberto BottiniLuigi DogliottiMaria Pia BrizziSergio AgugginiGiovanni AlleviDaniele GeneraliAlfredo BerrutiStephen B. Fox
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (4 papers)British Journal of Cancer (2 papers)
- Partner nations
- ItalyUnited KingdomAustralia
In The Last Decade
Alessandra Bersiga
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 658
- Oncology 641
- Pathology and Forensic Medicine 146
- Immunology 149
- Microbiology 5
Countries citing papers authored by Alessandra Bersiga
This map shows the geographic impact of Alessandra Bersiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bersiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bersiga more than expected).
Fields of papers citing papers by Alessandra Bersiga
This network shows the impact of papers produced by Alessandra Bersiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bersiga. The network helps show where Alessandra Bersiga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandra Bersiga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 34 | |
| 2 | 2011 | 5 | |
| 3 | 2011 | 6 | |
| 4 | 2011 | 22 | |
| 5 | 2010 | 12 | |
| 6 | Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis. | 2010 | 5 |
| 7 | 2009 | 129 | |
| 8 | 2008 | 7 | |
| 9 | 2008 | 45 | |
| 10 | 2007 | 12 | |
| 11 | 2007 | 12 | |
| 12 | 2006 | 66 | |
| 13 | 2004 | 30 | |
| 14 | 2003 | 35 | |
| 15 | Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. | 2002 | 41 |
| 16 | 2002 | 41 | |
| 17 | 2001 | 68 | |
| 18 | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. | 2000 | 103 |
| 19 | 1998 | 3 | |
| 20 | Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours. | 1996 | 54 |
About Alessandra Bersiga
Alessandra Bersiga is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Estrogen and related hormone effects (5 papers), Urinary and Genital Oncology Studies (3 papers), Breast Lesions and Carcinomas (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cancer Research (658 citations), Oncology (641 citations) and Pathology and Forensic Medicine (146 citations). Alessandra Bersiga has collaborated with scholars based in Italy, United Kingdom and Australia. Frequent co-authors include Alberto Bottini, Luigi Dogliotti, Maria Pia Brizzi, Sergio Aguggini, Giovanni Allevi, Daniele Generali, Alfredo Berruti, Stephen B. Fox, Adrian L. Harris and Manuela Milani. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.